Mason, OH, United States of America

Fangyi Luo

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Bowel Treatment: A Look at Inventor Fangyi Luo

Introduction: Fangyi Luo, an esteemed inventor based in Mason, OH, has made significant contributions to medical innovations, specifically in the field of treating inflammatory diseases of the bowel. With a total of two patents to his name, his work exemplifies the intersection of medicine and technology, aiming to improve treatment outcomes for patients affected by bowel diseases.

Latest Patents: Luo’s latest patents include groundbreaking methods for determining the efficacy of treatments for inflammatory diseases of the bowel. These novel techniques not only aid in screening potential treatments but also assess the efficacy response of individual patients to various treatment regimens. Additionally, he has developed kits that facilitate the utilization of these methods, providing valuable tools for researchers and healthcare providers.

Career Highlights: Currently, Fangyi Luo is associated with The Procter & Gamble Company, where he continues to drive innovation in healthcare. His career is characterized by a deep commitment to improving patient care through science and research, positioning him as a key player in his field.

Collaborations: Throughout his career, Luo has collaborated with notable colleagues such as Ker-Sang Chen and John Kevin Collins. These partnerships not only highlight his ability to work effectively in a team but also signify the collective effort that often leads to advancements in medical research and treatment options.

Conclusion: Fangyi Luo's contributions to the field of inflammatory bowel disease treatments represent a significant stride in medical innovation. His patents reflect a clear dedication to improving health outcomes through scientific exploration and collaboration. As he continues his work at The Procter & Gamble Company, the impact of his innovations is likely to resonate within the healthcare community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…